News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spaulding Clinical Research to Perform Bioequivalence Study for One of World's Largest Pharmaceutical Companies



9/13/2010 1:16:06 PM

WEST BEND, Wis.--(BUSINESS WIRE)--Spaulding Clinical, a Phase 1 Clinical Pharmacology Research Unit and Core ECG Lab announced today that it will serve as the Phase 1 clinical site for an upcoming bioequivalence study for one of the world’s top five pharmaceutical companies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES